agilon health, inc. (NYSE:AGL) Given Consensus Recommendation of “Hold” by Brokerages

Shares of agilon health, inc. (NYSE:AGL) have been assigned an average rating of “Hold” from the eighteen analysts that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $4.03.

A number of research firms have issued reports on AGL. Needham & Company LLC began coverage on shares of agilon health in a research report on Friday, January 10th. They set a “hold” rating for the company. Barclays cut their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Finally, TD Cowen reduced their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th.

Insider Transactions at agilon health

In related news, Director John William Wulf bought 45,000 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the purchase, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This represents a 27.93 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Diana Mckenzie purchased 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were acquired at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the transaction, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. This trade represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 90,000 shares of company stock worth $198,100. Insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

A number of hedge funds and other institutional investors have recently modified their holdings of AGL. Capital International Investors increased its stake in shares of agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after purchasing an additional 9,346,295 shares during the period. Millennium Management LLC increased its position in agilon health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock worth $13,704,000 after buying an additional 4,706,357 shares during the period. Citigroup Inc. increased its position in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the period. Algert Global LLC increased its position in agilon health by 1,042.7% during the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after buying an additional 1,924,157 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after acquiring an additional 1,498,524 shares during the period.

agilon health Stock Performance

Shares of agilon health stock opened at $3.43 on Thursday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a 50 day moving average price of $2.71 and a 200 day moving average price of $3.14. The firm has a market capitalization of $1.41 billion, a P/E ratio of -3.64 and a beta of 0.67. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.